Kurs & Likviditet
Beskrivning
Land | Norge |
---|---|
Lista | OAX Equities |
Sektor | Hälsovård |
Industri | Bioteknik |
2021-06-09 11:47:13
9.6.2021 11:47:11 CEST | Aqua Bio Technology ASA | Major shareholding
notifications
Edvard Cock has, as chairman of the Board of Directors of Aqua Bio Technology
ASA, received proxies to vote for 9 193 000 shares at the annual general meeting
on 9 June 2021 (the "AGM") without any voting instructions, representing approx.
46.65% of the total shares and votes in the company. Espen Kvale, as CEO,
received 8 734, representing 0.043%. The proxies received are only valid for the
AGM and will lapse automatically thereafter.
Further, Blixen Invest AS, a company wholly-owned by Edvard Cock, holds 1 280
793 shares in Aqua Bio Technology, and together with the received proxies,
Edvard Cock may therefore vote for 10 473 793 shares, representing approx.
53.15% of the votes in the company.
For further information, please contact Espen Kvale, CEO, telephone +47 9162
8092.
* * *
Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT's cosmetics ingredients are
highly effective and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skin care products developed by partners towards consumers and
professional users. ABT's focus on commercialization and development of natural
ingredients and natural skin care products has been, and will continue to be, an
important part of the Company's strategy going forward. ABT is listed on the
Euronext Expand market of the Oslo Stock Exchange.
This information is subject to the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.
DISCLOSURE REGULATION
This information is subject of the disclosure requirements pursuant to section
of 5-12 of the Norwegian Securities Trading Act.
CONTACTS
* Espen Kvale, CEO, +47 916 28 092, espen.kvale@aquabiotech.no
ABOUT AQUA BIO TECHNOLOGY ASA
Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT's cosmetics ingredients are
highly effective and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skin care products developed by partners towards consumers and
professional users. Aqua Bio Technology is listed on Euronext Expand.